Literature DB >> 20583981

Modifying radiation damage.

Kwanghee Kim1, William H McBride.   

Abstract

Radiation leaves a fairly characteristic footprint in biological materials, but this is rapidly all but obliterated by the canonical biological responses to the radiation damage. The innate immune recognition systems that sense "danger" through direct radiation damage and through associated collateral damage set in motion a chain of events that, in a tissue compromised by radiation, often unwittingly result in oscillating waves of molecular and cellular responses as tissues attempt to heal. Understanding "nature's whispers" that inform on these processes will lead to novel forms of intervention targeted more precisely towards modifying them in an appropriate and timely fashion so as to improve the healing process and prevent or mitigate the development of acute and late effects of normal tissue radiation damage, whether it be accidental, as a result of a terrorist incident, or of therapeutic treatment of cancer. Here we attempt to discuss some of the non-free radical scavenging mechanisms that modify radiation responses and comment on where we see them within a conceptual framework of an evolving radiation-induced lesion.

Entities:  

Mesh:

Year:  2010        PMID: 20583981      PMCID: PMC3079263          DOI: 10.2174/1389450111009011352

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  221 in total

1.  The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization.

Authors:  P D Arora; C A McCulloch
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 2.  Pharmacologic modification of radiation-induced late normal tissue injury.

Authors:  J E Moulder; M E Robbins; E P Cohen; J W Hopewell; W F Ward
Journal:  Cancer Treat Res       Date:  1998

3.  Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker.

Authors:  A Molteni; J E Moulder; E P Cohen; B L Fish; J M Taylor; P A Veno; L F Wolfe; W F Ward
Journal:  Exp Biol Med (Maywood)       Date:  2001-12

4.  Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death.

Authors:  P Dent; D B Reardon; J S Park; G Bowers; C Logsdon; K Valerie; R Schmidt-Ullrich
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

5.  Treatment of radiation nephropathy with ACE inhibitors.

Authors:  J E Moulder; B L Fish; E P Cohen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-09-01       Impact factor: 7.038

Review 6.  Toll-like receptors, wound healing, and carcinogenesis.

Authors:  Johannes Kluwe; Ali Mencin; Robert F Schwabe
Journal:  J Mol Med (Berl)       Date:  2008-12-17       Impact factor: 4.599

Review 7.  Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists.

Authors:  J E Moulder; B L Fish; E P Cohen
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

8.  Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.

Authors:  M Urano; M Kuroda; R Reynolds; T D Oberley; D K St Clair
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

9.  IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium.

Authors:  Laurence J Egan; Lars Eckmann; Florian R Greten; Sungwon Chae; Zhi-Wei Li; Gennett M Myhre; Sylvie Robine; Michael Karin; Martin F Kagnoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  TLK1B promotes repair of UV-damaged DNA through chromatin remodeling by Asf1.

Authors:  Siddhartha P Sen; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2006-10-20       Impact factor: 2.946

View more
  7 in total

1.  Potent radioprotective effects of combined regimens of famotidine and vitamin C against radiation-induced micronuclei in mouse bone marrow erythrocytes.

Authors:  M Zangeneh; H Mozdarani; A Mahmoudzadeh
Journal:  Radiat Environ Biophys       Date:  2015-01-30       Impact factor: 1.925

Review 2.  Novel Indications for Commonly Used Medications as Radiation Protectants in Spaceflight.

Authors:  Mark F McLaughlin; Dorit B Donoviel; Jeffrey A Jones
Journal:  Aerosp Med Hum Perform       Date:  2017-07-01       Impact factor: 1.053

Review 3.  Radiation and inflammation.

Authors:  Dörthe Schaue; Ewa D Micewicz; Josephine A Ratikan; Michael W Xie; Genhong Cheng; William H McBride
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

4.  IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor.

Authors:  Scott A Gerber; Abigail L Sedlacek; Kyle R Cron; Shawn P Murphy; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2013-04-12       Impact factor: 4.307

5.  Classes of Drugs that Mitigate Radiation Syndromes.

Authors:  Ewa D Micewicz; Robert D Damoiseaux; Gang Deng; Adrian Gomez; Keisuke S Iwamoto; Michael E Jung; Christine Nguyen; Andrew J Norris; Josephine A Ratikan; Piotr Ruchala; James W Sayre; Dörthe Schaue; Julian P Whitelegge; William H McBride
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

6.  Evaluation of Novel Tranexamic Acid/Montmorillonite Intercalation Composite, as a New Type of Hemostatic Material.

Authors:  Fei Ma; Shujing Sui; Zhiyuan Yang; Tong Ye; Lei Yang; Peng Han; Hui Gan; Zhuona Wu; Ruolan Gu; Xiaoxia Zhu; Fei Li; Zhiyun Meng; Zhiping Jiang; Guifang Dou
Journal:  Biomed Res Int       Date:  2022-02-28       Impact factor: 3.411

7.  Sodium orthovanadate (vanadate), a potent mitigator of radiation-induced damage to the hematopoietic system in mice.

Authors:  Bing Wang; Kaoru Tanaka; Akinori Morita; Yasuharu Ninomiya; Kouichi Maruyama; Kazuko Fujita; Yoshio Hosoi; Mitsuru Nenoi
Journal:  J Radiat Res       Date:  2013-01-24       Impact factor: 2.724

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.